A novel DHPLC-based procedure for the analysis of COL1A1 and COL1A2 mutations in osteogenesis imperfecta

Journal of Molecular Diagnostics

Volumn 13, Issue 6, 2011, Pages 648-656

  Fuccio, Antonella ^a   Iorio, Mariangela ^a   Amato, Felice ^a   Elce, Ausilia ^a   Ingino, Rosaria ^a   Filocamo, Mirella ^b   Castaldo, Giuseppe ^a,c   Salvatore, Francesco ^a,c   Tomaiuolo, Rossella ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c Scuola Europea di Medicina Molecolare SEMM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1;

ALLELE; ARTICLE; COL1A1 GENE; COL1A2 GENE; COST; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNA DETERMINATION; EXON; GENE EXPRESSION; GENE MUTATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HUMAN; INTRON; NUCLEOTIDE SEQUENCE; OSTEOGENESIS IMPERFECTA; PATIENT COUNSELING; POLYMERASE CHAIN REACTION; PRENATAL DIAGNOSIS; REPRODUCIBILITY;

EID: 82955245665     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2011.06.006     Document Type: Article

References (30)

1. Sillence DO, Senn A, Danks DM: Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979, 16:101-116 (Pubitemid 9164903)
2. Marini JC, Forlino A, Cabral WA, Barnes AM, San Antonio JD, Milgrom S, Hyland JC, Körkkö J, Prockop DJ, De Paepe A, Coucke P, Symoens S, Glorieux FH, Roughley PJ, Lund AM, Kuurila-Svahn K, Hartikka H, Cohn DH, Krakow D, Mottes M, Schwarze U, Chen D, Yang K, Kuslich C, Troendle J, Dalgleish R, Byers PH: Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mutat 2007, 28:209-221
3. Persikov AV, Pillitteri RJ, Amin P, Schwarze U, Byers PH, Brodsky B: Stability related bias in residues replacing glycines within the collagen triple helix (Gly-Xaa-Yaa) in inherited connective tissue disorders. Hum Mutat 2004, 24:330-337 (Pubitemid 39336639)
4. Rauch F, Lalic L, Roughley P, Glorieux FH: Genotype-phenotype correlations in nonlethal osteogenesis imperfecta caused by mutations in the helical domain of collagen type 1. Eur J Hum Genet 2010, 18:642-647
5. Willing MC, Deschenes SP, Slayton RL, Roberts EJ: Premature chain termination is a unifying mechanism for COL1A1 null alleles in osteogenesis imperfecta type I cell strains. Am J Hum Genet 1996, 59:799-809 (Pubitemid 26328075)
6. Bodian DL, Chan TF, Poon A, Schwarze U, Yang K, Byers PH, Kwok PY, Klein TE: Mutation and polymorphism spectrum in osteogenesis imperfecta type II: implications for genotype-phenotype relationships. Hum Mol Genet 2009, 18:463-471
7. Benusiene E, Kucinskas V: COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta. J Appl Genet 2003, 44:95-102 (Pubitemid 37123408)
8. Cheung MS, Glorieux FH: Osteogenesis imperfecta: update on presentation and management. Rev Endocr Metab Disord 2008, 9:153-160
9. Pepin M, Atkinson M, Starman BJ, Byers PH: Strategies and outcomes of prenatal diagnosis for osteogenesis imperfecta: a review of biochemical and molecular studies completed in 129 pregnancies. Prenat Diagn 1997, 17:559-570 (Pubitemid 27243696)
10. Ries L, Frydman M, Barkai G, Goldman B, Friedman E: Prenatal diagnosis of a novel COL1A1 mutation in osteogenesis imperfecta type I carried through full term pregnancy. Prenat Diagn 2000, 20:876-880
11. Castaldo G, Nardiello P, Bellitti F, Rocino A, Coppola A, di Minno G, Salvatore F: Denaturing HPLC procedure for factor IX gene scanning. Clin Chem 2003, 49:815-818 (Pubitemid 36513266)
12. Castaldo G, Nardiello P, Bellitti F, Santamaria R, Rocino A, Coppola A, di Minno G, Salvatore F: Haemophilia B: from molecular diagnosis to gene therapy. Clin Chem Lab Med 2003, 41:445-451
13. Frumkin D, Wasserstrom A, Itzkovitz S, Harmelin A, Rechavi G, Shapiro E: Amplification of multiple genomic loci from single cells isolated by laser micro-dissection of tissues. BMC Biotechnol 2008, 8:17
14. Elce A, Boccia A, Cardillo G, Giordano S, Tomaiuolo R, Paolella G, Castaldo G: Three novel CFTR polymorphic repeats improve segregation analysis for cystic fibrosis. Clin Chem 2009, 55:1372-1379
15. Willaert A, Malfait F, Symoens S, Gevaert K, Kayserili H, Megarbane A, Mortier G, Leroy JG, Coucke PJ, De Paepe A: Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation. J Med Genet 2009, 46:233-241
16. Marini JC, Cabral WA, Barnes AM: Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res 2010, 339:59-70
17. Baldridge D, Schwarze U, Morello R, Lennington J, Bertin TK, Pace JM, Pepin MG, Weis M, Eyre DR, Walsh J, Lambert D, Green A, Robinson H, Michelson M, Houge G, Lindman C, Martin J, Ward J, Lemyre E, Mitchell JJ, Krakow D, Rimoin DL, Cohn DH, Byers PH, Lee B: CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat 2008, 29:1435-1442 (Pubitemid 352774897)
18. Van Dijk FS, Nesbitt IM, Zwikstra EH, Nikkels PG, Piersma SR, Fratantoni SA, Jimenez CR, Huizer M, Morsman AC, Cobben JM, van Roij MH, Elting MW, Verbeke JI, Wijnaendts LC, Shaw NJ, Högler W, McKeown C, Sistermans EA, Dalton A, Meijers-Heijboer H, Pals G: PPIB mutations cause severe osteogenesis imperfecta. Am J Hum genet 2009, 85:521-527
19. Alanay Y, Avaygan H, Camacho N, Utine GE, Boduroglu K, Aktas D, Alikasifoglu M, Tuncbilek E, Orhan D, Bakar FT, Zabel B, Superti-Furga A, Bruckner-Tuderman L, Curry CJ, Pyott S, Byers PH, Eyre DR, Baldridge D, Lee B, Merrill AE, Davis EC, Cohn DH, Akarsu N, Krakow D: Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta. Am J Hum Genet 2010, 86:551-559
20. Christiansen HE, Schwarze U, Pyott SM, AlSwaid A, Al Balwi M, Alrasheed S, Pepin MG, Weis MA, Eyre DR, Byers PH: Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet 2010, 86:389-398
21. Venturi G, Tedeschi E, Mottes M, Valli M, Camilot M, Viglio S, Antoniazzi F, Tatò L: Osteogenesis imperfecta: clinical, biochemical and molecular findings. Clin Genet 2006, 70:131-139 (Pubitemid 44028098)
22. De Vos A, Sermon K, Van de Velde H, Joris H, Vandervorst M, Lissens W, De Paepe A, Liebaers I, Van Steirteghem A: Two pregnancies after preimplantation genetic diagnosis for osteogenesis imperfecta type I and type IV. Hum Genet 2000, 106:605-613 (Pubitemid 30427014)
23. Galicka A, Wolczynski S, Lesniewicz R, Chyczewski L, Gindzienski A: A novel Gly to Arg substitution at position 388 of the alpha1 chain of type I collagen in lethal form of osteogenesis imperfecta. Acta Biochim Pol 2002, 49:443-450 (Pubitemid 135686791)
24. Korkko J, Ala-Kokko L, De Paepe A, Nuytinck L, Earley J, Prockop DJ: Analysis of the COL1A1 and COL1A2 genes by PCR amplification and scanning by conformation-sensitive gel electrophoresis identifies only COL1A1 mutations in 15 patients with osteogenesis imperfecta type 1: identification of common sequences of null-allele mutations. Am J Hum Genet 1998, 62:98-110 (Pubitemid 28093839)
25. Castaldo G, Lembo F, Tomaiuolo R: Molecular diagnostics: between chips and customized medicine. Clin Chem Lab Med 2010, 48:973-982
26. Chan TF, Poon A, Basu A, Addleman NR, Chen J, Phong A, Byers PH, Klein TE, Kwok PY: Natural variation in four human collagen genes across an ethnically diverse population. Genomics 2008, 91:307-314
27. Benusiene E, Kucinskas V: Strategies for prenatal diagnosis of osteogenesis imperfecta by linkage analysis to the type I collagen loci COL1A1 and COL1A2. Med Sci Monit 2000, 6:217-226 (Pubitemid 30313152)
28. Raponi M, Baralle D: Alternative splicing: good and bad effects of translationally silent substitutions. FEBS J 2010, 277:836-840
29. Cooper TA: Use of minigene systems to dissect alternative splicing elements. Methods 2005, 37:331-340
30. Gaildrat P, Killian A, Martins A, Tournier I, Frébourg T, Tosi M: Use of splicing reported minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol Biol 2010, 653:249-257